IN8bio, Inc.

IN8bio, Inc.verified

INAB

Price:

$1.43

Market Cap:

$6.63M

IN8bio, Inc. is a biotechnology firm currently in the clinical trial phase, dedicated to identifying, advancing, and bringing to market gamma-delta T cell-based treatments specifically for various forms of cancer. The company's primary therapeutic asset, INB-200, is an autologous (patient-derived) gamma-delta T cell product that has been genetically engineered and is presently undergoing a Phase I clinical study for glioblastoma and other solid tumor malignancies. Additionally, INB-100, an allogeneic (donor-derived) candidate, is also in a Phase I clinical trial, aiming to treat acute leukemia patients undergoing hematopoietic stem cell transplantation. Further development includes preclinic...[Read more]

Industry

Biotechnology

IPO Date

2021-07-30

Stock Exchange

NASDAQ

Ticker

INAB

The Current Ratio as of June 2026 (TTM) for IN8bio, Inc. (INAB) is 10.50

According to IN8bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.50. This represents a change of 26.28% compared to the average of 8.32 of the last 4 quarters.

IN8bio, Inc. (INAB) Historical Current Ratio (quarterly & annually)

How has INAB Current Ratio performed in the past?

The mean historical Current Ratio of IN8bio, Inc. over the last ten years is 7.36. The current 10.50 Current Ratio has changed 14.16% with respect to the historical average. Over the past ten years (40 quarters), INAB's Current Ratio was at its highest in in the September 2021 quarter at 20.31. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

7.36

Median

5.81

Minimum

1.18

Maximum

17.28

IN8bio, Inc. (INAB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of IN8bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 498.19%

Maximum Annual Current Ratio = 17.28

Minimum Annual Increase = -90.26%

Minimum Annual Current Ratio = 1.18

Quarterly (TTM)
Annual
YearCurrent RatioChange
20258.82116.19%
20244.08-10.65%
20234.5719.56%
20223.82-77.90%
202117.28144.93%
20207.05498.19%
20191.18-90.26%

IN8bio, Inc. (INAB) Average Current Ratio

How has INAB Current Ratio performed in the past?

The current Current Ratio of IN8bio, Inc. (INAB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.82

5-year avg

7.71

10-year avg

7.36

IN8bio, Inc. (INAB) Current Ratio vs. Peers

How is INAB’s Current Ratio compared to its peers?

IN8bio, Inc.’s Current Ratio is greater than TransCode Therapeutics, Inc. (3.11), greater than Aptevo Therapeutics Inc. (3.36), greater than HCW Biologics Inc. (0.09), greater than Lyra Therapeutics, Inc. (1.71), greater than Kiora Pharmaceuticals, Inc. (6.68), less than Galecto, Inc. (22.48), greater than Aprea Therapeutics, Inc. (8.92), greater than Acurx Pharmaceuticals, Inc. (3.78), greater than BioCardia, Inc. (0.41), less than Phio Pharmaceuticals Corp. (66.93),

Build a custom stock screener for IN8bio, Inc. (INAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IN8bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IN8bio, Inc. (INAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IN8bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is IN8bio, Inc.'s Current Ratio?

How is the Current Ratio calculated for IN8bio, Inc. (INAB)?

What is the highest Current Ratio for IN8bio, Inc. (INAB)?

What is the 3-year average Current Ratio for IN8bio, Inc. (INAB)?

What is the 5-year average Current Ratio for IN8bio, Inc. (INAB)?

How does the current Current Ratio for IN8bio, Inc. (INAB) compare to its historical average?